眩晕复位治疗椅辅助治疗后半规管良性阵发性位置性眩晕的疗效观察

来源 :2014第四届全国耳鼻咽喉科医师大会 | 被引量 : 0次 | 上传用户：masonma

【摘要】

：

目的:评价复位治疗椅辅助复位治疗后半规管良性阵发性位置性眩晕(PSC-BPPV)的疗效.方法:回顾性分析了2012年2月至2012年4月我院眩晕中心连续诊治的165例PSC-BPPV患者,其中男性45例,女性121例;年龄范围为23 ～ 74岁;眩晕病史2d～11年;左耳患病67例,右耳患病98例,无双耳同时受累的患者.所有患者被随机分为Epely组和TRV Chair组分别接受Epely法复位和

【作者】

：

谭俊于栋祯冯艳梅游锦宋强时海波殷善开

【机构】

：

上海交通大学附属第六人民医院耳鼻咽喉科

【出处】

：

2014第四届全国耳鼻咽喉科医师大会

【发表日期】

：

2014年3期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Efficacy of CIK cell immunotherapy in patients with colorectal cancer

Objective: To evaluate the clinical efficacy of cytokine-induced killer cells (CIK) combined with chemotherapy/radiotherapy in the treatment of postoperative patients with colorectal cancer.Methods: B

会议

Colorectal cancerCIK treatmentOverall survival

Immune status assessment of DC-CIK treated patients with high tumor burden: a systematic analysis of

Objective: Immune status assessment of DC-CIK treated patient is an important basis for prognosis estimation.A systematic analysis was carried out to disclose the relationships among serological, immu

会议

DC-CIKlife qualitylong-term prognosis

Initial HAI and Systemic Chemotherapy Followed by Radical Surgery for Asymptomatic Colorectal Cancer

Background: Combining hepatic arterial infusion (HAI) with systemic chemotherapy is a proved strategy to improve resection rate in initially unresectable colorectal cancer liver metastases (CRCLM).How

会议

colorectal cancersynchronous liver metastaseshepatic artery infusionsurgeryc

Cytokine-Induced Killer Cells Co-cultured with Dendritic Cells Loaded with Protein Lysate produced b

Radiofrequency ablation (RFA) causes coagulative necrosis of tumor tissue and local tumor protein debris.These fragments of debris tumor protein contain large number kinds of antigens which can stimul

会议

Thermal ablationDendritic cellsCIK cellsColonAntigen loadProtein Lysate

A Preliminary Clinical Study on Using Adoptive Cellular Therapy Combined with Interferon Alpha in Im

Background and Aim: Approximately one third of the worlds population has serological evidence of past or present infection with hepatitis B virus (HBV) and that 350 to 400 million people are chronical

会议

Adoptive cellular therapyIFN-αchronic hepatitis B

Adoptive cell Therapy using T cells Engineered with Dual Signal-independent Chimeric Antigen Recepto

Objective: Chimeric antigen receptor (CAR)-engineered T cells (CAR-T) can destroy tumor cells expressing targeted tumor-associated antigen.However," On target, off tumor" effect is one of the most maj

会议

chimeric antigen receptorMUC 1EGFR

B7-H 1 expression associates with tumor invasion and predicts patient's survival in human esoph

B7-H 1, an important member of the B7-CD28 super family, has been reported to play an important role in regulation ofT-cell mediated anti-tumor response, and also has effect in the biological characte

会议

B7-H 1esophageal cancertissue microarraysurvival

Dissecting the molecular pathways of Glycogen Synthase Kinase-3 inhibition mediated self-renewal of

Background: CHIR99021, a GSK-3 specific inhibitor, promotes mouse and rat ESC self-renewal through inhibition of glycogen synthase kinase 3 (Gsk3) and subsequent negatively modulating Tcf3 via canonic

会议

Embryonic stem cellGlycogen Synthase Kinase 3 (Gsk3)Self-renewalTfcp211

Embryonic stem cells transformed into embryonic carcinoma cells during serial transplantation

To examine the mechanism underlying the self-renewal of pluripotent stem cells, we subcutaneously transplanted an Oct4-GFP (Oct4 promoter driving a green fluorescent protein reporter) mouse embryonic

会议

Embryonic stem cellOct4-expressiontransformationembryonic carcinoma cells

沿矢状位快速复位良性阵发性位置性眩晕的近远期疗效

目的:探讨该类良性阵发性位置性眩晕(benign paroxysmal positional vertigo,BBPV)患者的临床特点及沿矢状位快速翻转治疗此类BPPV患者的近远期疗效.方法:回顾分析2009年7月到2014年4月沿矢状位快速翻转手法复位诊治的84例在正中悬头位时诱发眩晕的BPPV患者的临床表现和疗效.结果:84例患者中女性患者55例,男性患者29例,年龄20到78岁,BPPV患者

会议

眩晕复位治疗椅辅助治疗后半规管良性阵发性位置性眩晕的疗效观察

与本文相关的学术论文